NCT07659197Completed
Usefulness of the VExUS Protocol for Dry-Weight Adjustment in Hemodialysis Patients: The Multicenter VExHD Study
Utilidad Del Protocolo VExUS en el Ajuste de Peso Ideal de Los Pacientes en hemodiálisis
Source: ClinicalTrials.gov · Last updated 24 Jun 2026
Brief summary (registry, in English)
The objective of this prospective observational study is to determine the utility of ultrasonographic assessment using the VExUS protocol for dry weight adjustment in clinically euvolemic patients undergoing hemodialysis. The primary hypothesis is that the assessment of venous congestion by ultrasound may help identify patients who can tolerate increased ultrafiltration, thereby improving blood pressure control. The comparison group will consist of patients who do not meet the criteria for venous congestion according to the VExUS protocol. In patients meeting the criteria for venous congestion, the ultrafiltration volume during hemodialysis will be increased.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 10 Jun 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- Fundación Senefro
- Diseases
- High blood pressure
- NCT number
- NCT07659197
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 1 Jan 2025 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with liver disease (liver cirrhosis, steatosis, portal vein thrombosis)
Other
- Clinical signs and symptoms of volume overload
- Severe tricuspid regurgitation
- Inability to hold one's breath
- Obesity
Who the study is looking for
- Patients over 18 years of age who are currently on hemodialysis (more than 90 days since the start of the program)
- A schedule of three days per week at the centers included in the study
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Infanta Leonor Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.